Mastitis Control Products Market Report 2026

The mastitis control products market size has grown strongly in recent years. It will grow from $2.01 billion in 2025 to $2.12 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising prevalence of mastitis in dairy cattle populations, increasing demand for high quality milk production, growth of veterinary healthcare infrastructure, expansion of commercial dairy farming operations, traditional reliance on antibiotics for infection control.

The mastitis control products market size is expected to see strong growth in the next few years. It will grow to $2.65 billion by 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to rising shift toward antibiotic free dairy production systems, increasing adoption of rapid diagnostic and preventive care solutions, growing demand for organic and residue free milk products, expansion of smart dairy farm monitoring technologies, increasing focus on animal welfare and sustainable livestock management practices. Major trends in the forecast period include data driven mastitis early detection and monitoring systems, antibiotic free and probiotic based udder health management solutions, sustainable and residue free dairy hygiene product development, automated milking hygiene and udder disinfection systems, rapid on farm diagnostic testing kits for mastitis detection.

The rising dairy production demand is anticipated to propel the growth of the mastitis control products market coming years. Dairy production refers to the process of producing milk and milk-based products from domesticated animals such as cows, buffaloes, goats, and sheep. The rise in dairy production is driven by increasing consumer demand for milk and dairy products, as growing populations and changing dietary preferences boost consumption. Mastitis control products help dairy production by preventing and treating udder infections, ensuring healthier cows, higher milk yield, and improved milk quality. For instance, in January 2026, according to the Bullvine, a Canada-based online community and information source for dairy breeding professionals, US milk production reached approximately 234.3 billion pounds, reflecting a 1.4% increase compared to 2025. Therefore, the rising dairy production demand is expected to drive the growth of the mastitis control products market.

Leading companies operating in the mastitis control products market are focusing on developing advanced solutions, such as rapid on-farm diagnostics, to enhance detection accuracy, reduce unnecessary antimicrobial use, and improve herd health management. Rapid on-farm diagnostics refers to quick, on-site tests that detect mastitis in dairy cows, enabling immediate treatment decisions. For example, in August 2023, Zoetis, a US-based animal health company, launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic that uses a simple flow dipstick test to detect Gram-positive mastitis within eight hours. The solution allows farmers and veterinarians to identify affected cows before the next milking, enabling targeted antimicrobial therapy, reducing unnecessary treatments, and supporting responsible antibiotic use.

In September 2024, Zoetis, a US-based provider of a comprehensive portfolio of mastitis control products, diagnostics, and vaccines designed for both lactating and dry cows, entered into a partnership with Danone. Through this partnership, Zoetis and Danone seek to improve dairy herd health and sustainability by applying genetics and farm management practices to prevent infections and encourage healthier cows, thereby supporting the goals of Mastitis Control Products. Danone is a France-based developer of science-based products aimed at controlling and reducing the incidence of mastitis in breastfeeding mothers.

Major companies operating in the mastitis control products market are Merck & Co, Boehringer Ingelheim, Ecolab Inc., Zoetis Inc., GEA Group AG, Elanco Animal Health, IDEXX Laboratories, Ceva Santé Animale, Virbac S. A., DeLaval Holding AB, Phibro Animal Health Corporation, Neogen Corporation, Vetoquinol, Norbrook Laboratories, Milkrite InterPuls, BouMatic LLC, Dairymaster, Bioveta a. s., Afimilk Ltd., ImmuCell Corporation.

North America was the dominating region in the mastitis control products market in 2025. Asia Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the mastitis control products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the mastitis control products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mastitis control products market consists of sales of intramammary antibiotic infusion tubes, intramammary antibiotic infusion tubes, on-farm diagnostic test kits, and udder hygiene sprays. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.